ArticleBioMed research international2018

Therapeutic Effects of Systemic Administration of the Novel RANKL-Modified Peptide, MHP1, for Ischemic Stroke in Mice.

Munehisa Shimamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.